Target Name: MIR643
NCBI ID: G693228
Review Report on MIR643 Target / Biomarker Content of Review Report on MIR643 Target / Biomarker
MIR643
Other Name(s): microRNA 643 | MIRN643 | MicroRNA 643 | mir-643 | hsa-miR-643 | hsa-mir-643 | Hsa-mir-643

MIR643: A Non-Coding RNA Molecule with Potential Therapeutic Applications

MicroRNA (miRNA) 643 is a non-coding RNA molecule that plays a critical role in various cellular processes. It is a key regulator of gene expression and has been implicated in a wide range of biological processes, including cell growth, differentiation, and metabolism . MIR643 has also been shown to be a potential drug target and biomarker, with potential therapeutic applications in a variety of diseases.

MIR643 is a member of the miRNA family, which are small non-coding RNAs that play a key role in post-transcriptional gene regulation. miRNAs are typically made from a hairless RNA template and have the ability to interact with target RNAs to either activate or repress their expression. This interaction between miRNAs and target RNAs is often accompanied by the cleavage of a phosphate group on the target RNA by the 26S rRNA enzyme, resulting in the formation of a double-stranded RNA molecule.

MIR643 is a non-coding RNA molecule that contains 643 amino acid residues. It has a length of approximately 290 nucleotides and has a single exon on its 5' end. MIR643 is predominantly expressed in the liver, with a also significant expression in the heart , pancreas, and spleen.

MIR643 has been shown to play a critical role in cellular processes by regulating the expression of various genes. For example, MIR643 has been shown to repress the expression of the gene encoding the enzyme superoxide dismutase (SOD), which is involved in the detoxification of superoxide radicals. This result suggests that MIR643 may have potential as a therapeutic agent against oxidative stress-induced diseases.

MIR643 has also been shown to play a key role in cell growth and metabolism. For example, MIR643 has been shown to be involved in the regulation of the expression of genes involved in cell cycle progression and apoptosis. This result suggests that MIR643 may have potential as a therapeutic agent against cancer.

MIR643 has also been shown to play a critical role in the regulation of inflammation. For example, MIR643 has been shown to be involved in the regulation of the expression of genes involved in the production of pro-inflammatory cytokines. This result suggests that MIR643 may have potential as a therapeutic agent against inflammatory diseases.

MIR643 has also been shown to play a critical role in the regulation of cellular processes related to metabolism. For example, MIR643 has been shown to be involved in the regulation of the expression of genes involved in glucose metabolism. This result suggests that MIR643 may have potential as a therapeutic agent against metabolic diseases.

In addition to its role in cellular processes, MIR643 has also been shown to have potential as a drug target. For example, MIR643 has been shown to be involved in the regulation of the expression of the gene encoding the enzyme adenosine deaminase (ADAM), which is involved in the production of adenosine, a molecule that has been shown to have a variety of potential therapeutic applications. Adenosine has been shown to have potential in treating a wide range of diseases, including cancer, heart disease, and neurodegenerative diseases.

MIR643 has also been shown to be involved in the regulation of the expression of the gene encoding the enzyme heat shock protein (HSP70), which is involved in the regulation of protein folding and stability. This result suggests that MIR643 may have potential as a therapeutic agent against protein folding-related diseases.

In conclusion, MIR643 is a non-coding RNA molecule that plays a critical role in various cellular processes. It is a key regulator of gene expression and has been implicated in a wide range of biological processes, including

Protein Name: MicroRNA 643

The "MIR643 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR643 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR644A | MIR645 | MIR646 | MIR646HG | MIR647 | MIR648 | MIR649 | MIR6499 | MIR650 | MIR6500 | MIR6501 | MIR6502 | MIR6503 | MIR6504 | MIR6505 | MIR6506 | MIR6507 | MIR6508 | MIR6509 | MIR651 | MIR6510 | MIR6511A1 | MIR6511A2 | MIR6511A3 | MIR6511A4 | MIR6511B1 | MIR6511B2 | MIR6512 | MIR6513 | MIR6514 | MIR6515 | MIR6516 | MIR652 | MIR653 | MIR654 | MIR655 | MIR656 | MIR657 | MIR658 | MIR659 | MIR660 | MIR661 | MIR662 | MIR663A | MIR663AHG | MIR663B | MIR664A | MIR664B | MIR665 | MIR668 | MIR670 | MIR671 | MIR6715A | MIR6715B | MIR6716 | MIR6717 | MIR6718 | MIR6719 | MIR6720 | MIR6721 | MIR6722 | MIR6724-1 | MIR6726 | MIR6727 | MIR6728 | MIR6729 | MIR6730 | MIR6731 | MIR6732 | MIR6733 | MIR6734 | MIR6735 | MIR6736 | MIR6737 | MIR6738 | MIR6739 | MIR6740 | MIR6741 | MIR6742 | MIR6743 | MIR6744 | MIR6746 | MIR6747 | MIR6748 | MIR6749 | MIR675 | MIR6750 | MIR6751 | MIR6752 | MIR6753 | MIR6754 | MIR6755 | MIR6756 | MIR6757 | MIR6758 | MIR6759 | MIR676 | MIR6760 | MIR6761 | MIR6762